![]() |
市场调查报告书
商品编码
1492503
细胞冷冻介质市场:按类型、应用和最终用途分类 - 2024-2030 年全球预测Cell Freezing Media Market by Type (Dimethyl Sulfoxide-based Media, Glycerol-Based Media, Serum-Free Media), Application (Biobanking, Cancer Research, Genetic Engineering & CRISPR Technology), End-Use - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
细胞冷冻介质市场规模预计2023年为1.8571亿美元,2024年达到2.0166亿美元,预计2030年将达到3.3325亿美元,复合年增长率为8.71%。
细胞冷冻介质是一种在极低温下储存细胞的专用解决方案。二甲基亚砜(DMSO) 和甘油等冷冻保护剂的均衡混合物可保护细胞在冷冻过程中免受结晶形成。这些冷冻保护剂对于最大限度地减少细胞损伤并在解冻过程中维持细胞活力和功能至关重要。对先进生物製药的需求不断增长以及细胞治疗领域的成长进一步促进了细胞冷冻介质市场的繁荣。这些治疗方法在很大程度上依赖细胞保存,有效的冷冻介质的作用至关重要。然而,先进保存技术的高成本以及细胞处理和储存的严格监管要求给製造商和供应商带来了巨大的挑战。企业在这种环境中保持敏捷,努力降低成本并遵守法规。客製化冷冻解决方案的开发、新兴市场的成长以及人工智慧和物联网等最尖端科技的整合以改善冷冻保存结果都可以看到扩展机会。
主要市场统计 | |
---|---|
基准年[2023] | 1.8571 亿美元 |
预测年份 [2024] | 20166万美元 |
预测年份 [2030] | 33325万美元 |
复合年增长率(%) | 8.71% |
区域洞察
美国和加拿大因其强大的生物技术领域、大量的研发投资以及大型製药公司的存在而处于细胞冷冻介质市场的前沿。与冷冻保存技术和配方相关的创新和专利经常被报导,显示对先进细胞冷冻解决方案的高需求。细胞疗法和再生医学的采用进一步推动了该地区的市场成长。欧洲、中东和非洲细胞冷冻介质市场具有前瞻性,非常注重品质、创新和遵守严格的监管标准。该地区对干细胞研究、个人化医疗和生物库的关注促进了对复杂细胞冷冻解决方案的稳定需求。研究合作和欧盟资助的倡议在市场动态中发挥重要作用。随着研究活动投资的增加,中东和非洲地区正在经历适度的市场成长,并且对细胞疗法的认识不断增强,正在推动市场的发展。此外,由于生物技术的显着进步以及对长期细胞保存的冷冻保存方法的日益青睐,亚太地区的细胞冷冻介质市场正在稳步扩张。研究和开发活动、生物库的增加以及中国、日本和印度等国家对再生医学需求的激增进一步推动了这种成长。此外,政府旨在加强医疗基础设施和增加对製药和生物製药行业投资的措施也促进了市场的积极成长。
FPNV定位矩阵
FPNV 定位矩阵对于评估供应商在细胞冷冻介质市场的定位至关重要。此矩阵提供了对供应商的全面评估,并检查了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可对细胞冷冻介质市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献,您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外,该分析还提供了对该行业竞争力的宝贵见解,包括研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以在市场竞争中保持领先地位。
策略分析与建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对细胞冷冻介质市场当前地位的全面评估使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[187 Pages Report] The Cell Freezing Media Market size was estimated at USD 185.71 million in 2023 and expected to reach USD 201.66 million in 2024, at a CAGR 8.71% to reach USD 333.25 million by 2030.
Cell freezing media is a specialized solution to preserve cells in extremely low temperatures. It comprises a balanced mixture of cryoprotectants, such as dimethyl sulfoxide (DMSO) and glycerol, protecting the cells from ice crystal formation during freezing. These cryoprotectants are crucial in minimizing cellular damage and maintaining cell viability and functionality upon thawing. The surging demand for advanced biopharmaceuticals and the growing cell therapy sector further contribute to the positive trajectory of the cell freezing media market. These therapies rely extensively on the preservation of cells, making the role of effective freezing media indispensable. However, the high cost of advanced preservation technologies and stringent regulatory requirements for cell handling and storage pose significant challenges for manufacturers and suppliers. Companies frequently work towards cutting costs and adhering to regulations to remain agile within the landscape. Expansion opportunities are seen in developing customized freezing solutions, growth in emerging markets, and integrating cutting-edge technologies such as AI and IoT to refine cryopreservation outcomes.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 185.71 million |
Estimated Year [2024] | USD 201.66 million |
Forecast Year [2030] | USD 333.25 million |
CAGR (%) | 8.71% |
Regional Insights
In America, the United States, and Canada stand at the forefront of the cell-freezing media market, owing to its robust biotechnology sector, substantial research and development investments, and major pharmaceutical companies. Innovations and patents in cryopreservation techniques and formulations are frequently reported, demonstrating a high demand for advanced cell freezing solutions. Adopting cell therapy and regenerative medicine further propels market growth in the region. The EMEA market for cell freezing media is advanced, strongly emphasizing quality, innovation, and compliance with stringent regulatory standards. The region's focus on stem cell research, personalized medicine, and biobanking contribute to a steady demand for sophisticated cell freezing solutions. Research collaborations and EU-funded initiatives play a significant role in market dynamics. The Middle East and Africa region are experiencing gradual growth in the cell freezing media market with rising investment in research activities, and increasing awareness about cell-based therapies contributes to market evolution. Moreover, the Asia Pacific region is experiencing a robust expansion in the cell freezing media market, owing to significant advancements in biotechnology and an increasing inclination towards cryopreservation methods for long-term cell storage. A rise in research and development activities, biobanking, and a surge in demand for regenerative medicine across countries such as China, Japan, and India further fuels this growth. Additionally, government initiatives aimed at bolstering healthcare infrastructure, along with growing investments in the pharmaceutical and biopharmaceutical sectors, are contributing to the positive trajectory of the market.
Market Insights
The market dynamics represent an ever-changing landscape of the Cell Freezing Media Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Cell Freezing Media Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Cell Freezing Media Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Sartorius completes acquisition of Polyplus
Sartorius, an entity in the life sciences sector, completed the acquisition of Polyplus through its subsidiary, Sartorius Stedim Biotech. Polyplus specializes in developing and producing pivotal transfection reagents in viral vector manufacturing. This acquisition augments Sartorius's capabilities in this domain and signifies Polyplus's expansion into complementary technologies. By venturing into plasmid design and protein and plasmid production, Polyplus is diversifying its offerings and enhancing its technological portfolio to better serve the evolving needs of gene-modified cell and gene therapies. [Published On: 2023-07-18]
Qkine and Sartorius Partnership Delivers a Complete Workflow Solution for the Analysis of Advanced Cell Models
Qkine partnered with Sartorius to enrich stem cell and organoid research by integrating Qkine's expertise in creating bioactive growth factors and cytokines with Sartorius's advanced portfolio of cell analysis technologies. Sartorius, celebrated for accelerating life science research and pharmaceutical development, offers a broad spectrum of products, including reagents, assays, and pioneering technologies such as automated cell culture and live-cell imaging. This partnership is positioned to propel advancements in biologic discovery, streamline cell line development processes, and enhance the development of sophisticated cell models, thus delivering a holistic workflow solution to the scientific community. [Published On: 2023-07-06]
ExCell Bio Launches a New Factory in Uruguay
ExCell Biotechnology Co., Ltd. celebrated the opening of its new facility, ARTICA BIOTECH S.A. This significant milestone occurred within the Zonamerica Free Trade Zone on the northeastern outskirts of Montevideo, Uruguay. ExCell Bio has distinguished itself through its dedication to innovation in developing upstream tools for the biopharmaceutical industry. The inauguration of ARTICA BIOTECH S.A. marks the company's second establishment in Uruguay. ExCell Bio has achieved a significant position in China's market segment with its serum product line, underscoring its commitment to excellence and growing influence in the global marketplace. [Published On: 2023-05-04]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Cell Freezing Media Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Cell Freezing Media Market, highlighting leading vendors and their innovative profiles. These include Abcam Limited, AMSBIO, Inc., Bio-Rad Laboratories, Inc., Bio-Techne Corporation, BPS Bioscience, Inc., Capricorn Scientific, Carl Roth GmbH + Co. KG, Celprogen Corporation, Charles River Laboratories, Elabscience Bionovation Inc., ExCell Biotechnology Co., Ltd, Funakoshi Co., Ltd., HiMedia Laboratories, Merck KGaA, NIPPON Genetics EUROPE GmbH, PAN-Biotech GmbH, PromoCell GmbH, Qiagen NV, Sartorius AG, STEMCELL Technologies, Thermo Fisher Scientific Inc., and WELGENE Inc..
Market Segmentation & Coverage